This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Assurant (AIZ) This Earnings Season?
by Zacks Equity Research
Assurant's (AIZ) fourth-quarter results are likely to reflect better performance at Global Automotive and Connected Living as well as solid growth in Multifamily housing.
What's in the Cards for Everest Re (RE) This Earnings Season?
by Zacks Equity Research
Everest Re's (RE) Q4 results are likely to benefit from high renewal retention, new business opportunities, higher net investment income and underwriting profitability.
Will Willis Towers (WTW) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) fourth-quarter results are likely to reflect the impact of growth in Medicare Advantage and Life sales, strong renewals and new business activity.
What's in the Cards for CME Group (CME) in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) fourth-quarter performance is likely to have been aided increased trading activity and lower costs.
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AON to Announce Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
AON's fourth-quarter results are likely to reflect new business generation, growth in capital market transactions and increased operating costs.
Cboe Global (CBOE) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Cboe Global's (CBOE) fourth-quarter results are likely to have benefited from higher transaction fees driven by higher volumes traded, market data fees and access and capacity fees, and regulatory fees
Is Arch Capital Group (ACGL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Arch Capital Group (ACGL) and Ares Capital (ARCC) have performed compared to their sector so far this year.
What's in Store for Hartford Financial (HIG) Q4 Earnings?
by Zacks Equity Research
Hartford Financial's (HIG) Q4 earnings results are likely to reflect steep expenses, partly offset by higher revenues and a solid contribution from its Commercial Lines, Hartford Funds and Corporate segments.
Will Lower Net Investment Income Hurt MetLife (MET) Q4 Earnings?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to reflect volume growth and sound contribution from the Latin America segment.
Allstate (ALL) to Post Q4 Earnings Beat on Benefits Profits
by Zacks Equity Research
Allstate's (ALL) fourth-quarter results are likely to reflect improved net premiums earned from the Property Liability business.
Intercontinental (ICE) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Improved results at Exchanges, Fixed Income and Data Services, and Mortgage Technology segments are likely to aid fourth-quarter results of Intercontinental (ICE).
Will Prudential (PRU) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q4 results are likely to reflect strong investment performance, higher earnings from joint venture investments and higher variable life sales.
Can Aflac (AFL) Sustain its Surprise Streak in Q4 Earnings?
by Zacks Equity Research
Aflac's (AFL) fourth-quarter results are likely to reflect strong premium persistency rates, higher adjusted net investment income and lower benefit ratios, partly offset by elevated costs.
Chubb (CB) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Chubb (CB) Q4 earnings are likely to have been impacted by improved pricing, strong renewal retention, commercial premium growth and higher private equity distributions.
Unum Group (UNM) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Unum Group (UNM) Q4 is likely to benefit from favorable persistency trends, higher sales in the dental and vision product line and solid performance in alternative asset portfolio.
MetLife (MET) Unit Assumes U.K. Pension Scheme's Longevity Risks
by Zacks Equity Research
Aided by Zurich, MetLife's (MET) subsidiary completes a reinsurance deal with an aim to boost its presence in the U.K. longevity risk transfer market.
Is a Beat in Store for Marsh & McLennan (MMC) in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect rate increases, and solid results of Risk and Insurance Services and Consulting segments, partly offset by higher costs.
Will W.R. Berkley (WRB) Retain Beat Streak in Q4 Earnings?
by Zacks Equity Research
W.R. Berkley's (WRB) fourth-quarter results are likely to benefit from solid performance of Insurance and Reinsurance & Monoline Excess segments.
Allstate (ALL) Announces December and Q4 Cat Loss Estimates
by Zacks Equity Research
Allstate (ALL) discloses catastrophe loss estimates for December and the fourth quarter of 2021. However, ALL remains well-equipped to counter them with reinsurance programs.
RenaissaceRe (RNR) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter results are likely to reflect higher premiums, new business growth and rate increases across business lines, partly offset by elevated costs.
What's in the Cards for Progressive (PGR) in Q4 Earnings?
by Zacks Equity Research
Improved rates, solid policies in force and higher retention in its strong performing Vehicle and Property businesses are likely to have aided Progressive's (PGR) Q4 earnings.
Are Investors Undervaluing These Finance Stocks Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Retain W.R. Berkley (WRB) Stock in Your Portfolio?
by Zacks Equity Research
W.R. Berkley (WRB) is poised to benefit from underwriting profits, high retention and sufficient liquidity.